Wealthspire Advisors (New York)
GILD icon

Wealthspire Advisors (New York)’s Gilead Sciences GILD Stock Holding History

Wealthspire Advisors (New York)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Buy
3,477
+803
+30% +$106K ﹤0.01% 849
2026
Q1 		$373K Sell
2,674
-6,255
-70% -$876K ﹤0.01% 664
2025
Q4 		$1.1M Buy
8,929
+6,937
+348% +$843K 0.01% 411
2025
Q3 		$221K Sell
1,992
-689
-26% -$78.3K ﹤0.01% 761
2025
Q2 		$297K Buy
2,681
+437
+19% +$46.5K ﹤0.01% 668
2025
Q1 		$251K Sell
2,244
-442
-16% -$45.6K ﹤0.01% 684
2024
Q4 		$248K Buy
+2,686
New +$242K ﹤0.01% 689
2023
Q1 		– Sell
-5,368
Closed -$461K – 555
2022
Q4 		$461K Buy
+5,368
New +$425K 0.01% 381
2022
Q1 		– Sell
-6,716
Closed -$488K – 483
2021
Q4 		$488K Sell
6,716
-261
-4% -$18K 0.01% 325
2021
Q3 		$487K Buy
+6,977
New +$490K 0.01% 360
2021
Q2 		– Sell
-9,177
Closed -$593K – 492
2021
Q1 		$593K Buy
9,177
+2,426
+36% +$156K 0.01% 353
2020
Q4 		$393K Sell
6,751
-566
-8% -$34.2K 0.01% 354
2020
Q3 		$462K Sell
7,317
-2,707
-27% -$188K 0.03% 191
2020
Q2 		$771K Sell
10,024
-7,947
-44% -$609K 0.05% 121
2020
Q1 		$1.34M Buy
17,971
+12,644
+237% +$874K 0.06% 162
2019
Q4 		$346K Buy
5,327
+99
+2% +$6.45K 0.03% 132
2019
Q3 		$331K Buy
+5,228
New +$342K 0.03% 108
2019
Q1 		– Sell
-850
Closed -$53K – 336
2018
Q4 		$53K Buy
+850
New +$59.4K 0.01% 178

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wealthspire Advisors (New York)'s GILD Position: Q2 2026 in Review

Wealthspire Advisors (New York) increased its Gilead Sciences (GILD) stake by 30% in Q2 2026, buying an estimated $106K and bringing the position to 3,477 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Wealthspire Advisors (New York) first reported a position in GILD in Q4 2018 and has held it in 18 quarters since. The position peaked at $1.34M in Q1 2020. 2,292 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wealthspire Advisors (New York) held 3,477 shares of Gilead Sciences worth $439K as of Q2 2026.
  • Wealthspire Advisors (New York) bought 803 Gilead Sciences shares in Q2 2026, an estimated $106K.
  • Gilead Sciences made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #849 holding.
  • Wealthspire Advisors (New York) first reported a position in Gilead Sciences in Q4 2018 and has held it in 18 quarters since.
  • Wealthspire Advisors (New York)'s Gilead Sciences position peaked at $1.34M in Q1 2020.
  • 2,292 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.